The trademark application Gabapentin Aristo long was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 19, 2022, and it was registered by office on September 26, 2022 without any oppositions.
The application was filed in Swedish (German was selected as the second language).